An Open-label Study of the Effect of Continuous Xeloda Therapy in Combination With Irinotecan on Treatment Response in Patients With Advanced and/or Metastatic Colorectal Cancer
Phase of Trial: Phase II
Latest Information Update: 08 Jul 2015
At a glance
- Drugs Capecitabine (Primary) ; Irinotecan
- Indications Colorectal cancer
- Focus Therapeutic Use
- Sponsors Roche
- 23 Feb 2010 New source identified and integrated (Roche; MO16460).
- 16 Oct 2008 New trial record.